CLN.SW stock opened pre-market at CHF 7.65 on 06 Mar 2026 as trading activity topped 1,146,747 shares, making Clariant AG one of the most active names on the SIX. The price is down 0.55 points or -0.71% from the previous close of CHF 7.71. Volume is 1.24x average, signalling heavier order flow ahead of sector updates and company catalysts. We summarise the key drivers, valuation, technical signals, and short-term price scenarios to help traders and investors parse the move.

Pre-market snapshot and why CLN.SW stock is most active

Clariant AG (CLN.SW) is trading on the SIX in Switzerland at CHF 7.65 with a pre-market range of CHF 7.63–7.87. Volume of 1,146,747.00 shares exceeds the 50-day average of 924,127.00, marking it among the day’s most active Swiss-listed stocks.

Higher volume is concentrated around the CHF 7.60–7.80 band. Traders cite sector news and pending catalysts for Care Chemicals and Catalysis as triggers for elevated activity.

Fundamentals: valuation, earnings and dividend snapshot for CLN.SW stock

Clariant reports EPS CHF 0.34 and a price-to-earnings multiple at 22.49 from the intraday quote. Market capitalisation is CHF 2.51B and shares outstanding are 328,285,611.00.

Key ratios: price-to-book 1.23, price-to-sales 0.64, and free cash flow yield about 9.32%. Dividend per share is CHF 0.42, yielding roughly 5.49%. These metrics place Clariant near the Basic Materials peer group average PE of 18.50, indicating a modest premium versus some peers.

CLN.SW stock technical snapshot and trading signals

Price sits slightly above the 50-day average (CHF 7.61) and below the 200-day average (CHF 7.79). Momentum indicators show RSI 44.33 and MACD histogram -0.08, signalling neutral-to-mild downside pressure.

Volatility bands: Bollinger middle CHF 8.11, lower CHF 7.56. On-balance volume is positive at 3,349,787.00, but stochastic readings (%K 13.67) point to short-term oversold conditions that can attract fast buyers.

Meyka AI grade, analyst view and price targets for CLN.SW stock

Meyka AI rates CLN.SW with a score out of 100: 65.76 / Grade B — HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The internal score balances improving margins and free cash flow against leverage and mixed earnings trends.

Realistic price targets: conservative CHF 6.50, base CHF 8.50, bullish CHF 10.50. These targets reflect current PE range, cash flow multiples (p/FCF 10.73) and the company’s sector positioning. Targets are model-based, not guarantees.

Meyka AI’s forecast and scenario math

Meyka AI’s forecast model projects a quarterly target of CHF 8.62 and a monthly target of CHF 5.89. Compared with the current CHF 7.65, the quarterly forecast implies an upside of 12.68%, while the monthly forecast implies a downside of -23.01%. The yearly model output is CHF 3.45, implying -54.86% versus today.

Forecasts are model-based projections and not guarantees. Use them as scenario inputs, not as certainty.

Catalysts, sector context and key risks for CLN.SW stock

Catalysts: segment margin releases for Care Chemicals, catalyst contract rollouts, and clearer guidance at the next earnings announcement on 2026-07-31.

Risks: leverage metrics show debt-to-equity 1.07 and interest coverage near 1.19, signalling vulnerability to slower demand or higher rates. Sector pressures in Basic Materials and commodity swings can widen earnings volatility.

Final Thoughts

CLN.SW stock is trading pre-market at CHF 7.65 on 06 Mar 2026 with elevated volume and mixed signals. Fundamentals show steady cash flow and a CHF 0.42 dividend, but leverage and a negative recent net income per share pattern require caution. Technically, the stock is near the 50-day moving average with oversold short-term indicators that could attract bounce buyers. Meyka AI rates CLN.SW with a score out of 100 at 65.76 (Grade B, HOLD) and offers scenario price targets from CHF 6.50 to CHF 10.50. Meyka AI’s forecast model projects a quarterly level of CHF 8.62, implying ~12.68% upside, while monthly and yearly projections show downside scenarios; forecasts are model-based projections and not guarantees. For most-active traders, watch volume bands, catalyst dates, and the upcoming earnings window on SIX. For longer-term investors, weigh dividend yield 5.49% against leverage and sector cyclicality. Refer to company filings at Clariant and our internal page for live updates at Meyka: CLN.SW.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.